Mr. Plunkett will be responsible for the company’s U.S. operations. He previously was managing director with First Marblehead in Boston and spent 24 years in the U.S. Navy, retiring with the rank of Captain in July 2003.
More Articles on Spine Devices:
Synthes Signs Licensing Agreement With Kuros
Ascendx Spine Receives FDA Clearance for Vertebral Augmentation System
17 Spine Devices Receive FDA 510(k) Clearance in February
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.